DOSTARLIMAB

UNII: P0GVQ9A4S5
Preferred Substance Name: DOSTARLIMAB

2022215-59-2
DOSTARLIMAB [INN]
DOSTARLIMAB [USAN]
DOSTARLIMAB [WHO-DD]
DOSTARLIMAB GXLY [WHO-DD]
DOSTARLIMAB-GXLY
GSK4057190
GSK-4057190
IMMUNOGLOBULIN G4, ANTI-(PROGRAMMED CELL DEATH PROTEIN 1 (PDCD1)) (HUMANIZED CLONE ABT1 .GAMMA.4-CHAIN), DISULFIDE WITH HUMANIZED CLONE ABT1 .KAPPA.-CHAIN, DIMER
JEMPERLI
TSR042
TSR-042
WBP285
WBP-285

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

DOSTARLIMAB

Synonyms and Mappings

Resources

Note